Paul, Weiss is advising Canadian base metals mining company Lundin Mining Corporation in its all-cash $1.1 billion offer for Nevsun Resources Ltd, a Vancouver-based metals company....
Lundin Mining Corp.’s Unsolicited $1.1 Billion Offer for Nevsun Resources
Bio-Techne’s $325 Million Acquisition of Exosome Diagnostics
Goodwin advised Exosome Diagnostics on its definitive agreement to be acquired by Bio-Techne Corporation for $250 million in cash plus contingent consideration of up to $325...
Magenta Therapeutics’s Initial Public Offering
Goodwin advised Magenta on the offering Magenta Therapeutics (“MGTA”), a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to...
Bluebird bio’s strategic collaboration with Regeneron
Goodwin advised bluebird bio on its strategic collaboration with Regeneron to apply their respective technology platforms to the discovery, development and commercialization of novel immune cell...
Natera, Inc.’s $103 Million Follow-on Public Offering
Gunderson Dettmer advised Natera, Inc. in a follow-on public offering of 5,175,000 shares at the price to the public of $20.00 per share for a total...
Chandler v. Janssen Pharms. Inc., et al.
Patterson Belknap Webb & Tyler LLP successully advised Janssen Pharms on the Risperdal Gynecomastia Case On a motion for summary judgment, our lawyers successfully argued that...
Neon Therapeutics’ $100 Million Initial Public Offering
Goodwin advised Neon Therapeutics on the deal Neon Therapeutics (“NTGN”), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, closed its public offering of 6,250,000 shares of common...
Eidos Therapeutics’ $122 Million Initial Public Offering
Goodwin advised Eidos Therapeutics on the transaction Eidos Therapeutics (“EIDX”), a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases...
NexPhase Capital, LP’s Investment in Brandt Information Services, LLC
Lowenstein Sandler represented NexPhase Capital, LP (NexPhase) in its equity stake investment in Brandt Information Services, LLC (Brandt). NexPhase is an independent private equity firm making...
Aerpio Pharmaceuticals, Inc.’s $45.0 million public offering of common stock
Goodwin advised Aerpio Pharmaceuticals, Inc. on its $45.0 million public offering of common stock and uplisting to the Nasdaq Capital Market. The company’s common stock began...
EQT’s Acquisition of Zemax Software Holdings
Sheppard Mullin Represents Arlington Capital’s Portfolio Company, Zemax, in the sale has acquired Zemax Software Holdings, LLC., a leading global provider of optical and illumination design...
Toast’s $115 million Series D funding
Goodwin advised Toast on the transaction Toast closed a $115 million Series D funding round that values the company at $1.4 billion. The financing round was...